Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) confirms today that it intends to release on Monday, 29 June 2020 its financial results for the year ended 31 March 2020. The release will be issued shortly before 9:00am NZDT, 7:00am AEST (5:00pm USEDT, Sunday, 28 June).
Fisher & Paykel Healthcare will host a conference call on Monday, 29 June 2020 to review the results and to discuss the outlook for the 2021 financial year. The conference call is scheduled to begin at 10:00am NZDT, 8:00am AEST (6:00pm USEDT, Sunday, 28 June) and will be broadcast simultaneously over the Internet.
To listen to the webcast, access the company’s website at www.fphcare.com/investor. An online archive of the event will be available approximately two hours after the webcast and will remain on the site for two weeks.
To attend the conference call, dial in to one of the numbers below at least five minutes prior to the scheduled call time and identify yourself to the operator. When prompted, please provide the conference code of: 609752.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Ends
Contact
Investors:
Hayden Brown Investor Relations Manager hayden.brown@fphcare.co.nz +64 (0) 27 807 8073
Media:
Karen Knott Senior Communications Manager karen.knott@fphcare.co.nz +64 (0) 21 713 911
Fisher & Paykel Healthcare confirms full year results to be released on 29 June 2020
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
We value your privacy. Our websites and applications use cookies to function properly and securely.